NSC |
Compound |
Enrichment |
Correlation |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0392716453377535 |
-0.048589491 |
NSC 732492 |
Null |
0.0392716453377535 |
0.27888132 |
NSC 733476 |
Null |
0.0392716453377535 |
0.22514896 |
NSC 753427 |
2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol |
0.0392716453377535 |
0.16504684 |
NSC 763236 |
Null |
0.0392716453377535 |
0.23732192 |
NSC 90736 |
Null |
0.0392716453377535 |
0.083279966 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0403978426119736 |
-0.021348629 |
NSC 30915 |
Null |
0.0403978426119736 |
0.37904597 |
NSC 32951 |
Acetic acid, (2,4-dihydroxy-2H-pyran-3(6H)-ylidene)-, 3,4-lactone |
0.0403978426119736 |
0.55577508 |
NSC 33570 |
Null |
0.0403978426119736 |
0.39444954 |